Iacob, S.; Stefan, C.-S.; Nechita, A.; Matei, M.-N.; Lisa, E.-L.; Tutunaru, D.; Fulga, I.; Fulga, A.; Cristea, A.-G.; Dragostin, O.-M.
Hybrid Molecules with Purine and Pyrimidine Derivatives for Antitumor Therapy: News, Perspectives, and Future Directions. Molecules 2025, 30, 2707.
https://doi.org/10.3390/molecules30132707
AMA Style
Iacob S, Stefan C-S, Nechita A, Matei M-N, Lisa E-L, Tutunaru D, Fulga I, Fulga A, Cristea A-G, Dragostin O-M.
Hybrid Molecules with Purine and Pyrimidine Derivatives for Antitumor Therapy: News, Perspectives, and Future Directions. Molecules. 2025; 30(13):2707.
https://doi.org/10.3390/molecules30132707
Chicago/Turabian Style
Iacob (Ciobotaru), Simona, Claudia-Simona Stefan, Aurel Nechita, Madalina-Nicoleta Matei, Elena-Lacramioara Lisa, Dana Tutunaru, Iuliu Fulga, Ana Fulga, Alina-Georgiana Cristea (Hohota), and Oana-Maria Dragostin.
2025. "Hybrid Molecules with Purine and Pyrimidine Derivatives for Antitumor Therapy: News, Perspectives, and Future Directions" Molecules 30, no. 13: 2707.
https://doi.org/10.3390/molecules30132707
APA Style
Iacob, S., Stefan, C.-S., Nechita, A., Matei, M.-N., Lisa, E.-L., Tutunaru, D., Fulga, I., Fulga, A., Cristea, A.-G., & Dragostin, O.-M.
(2025). Hybrid Molecules with Purine and Pyrimidine Derivatives for Antitumor Therapy: News, Perspectives, and Future Directions. Molecules, 30(13), 2707.
https://doi.org/10.3390/molecules30132707